A2073
Product Specifications
CAS Number
2834742-70-8
Target
Akt, NF-κB, p38 MAPK, PI3K
Related Pathways
Cytoskeletal Signaling, NF-κB, PI3K/Akt/mTOR signaling, MAPK
Bioactivity
A2073 is a flavonoid derivative that inhibits the proliferation of erythroleukemia cells by inducing cell cycle arrest and suppressing the MAPK, NF-κB, and PI3K signaling pathways. It forms stable interactions with cell cycle-related proteins (CDK1, CCNA2, PRIM1) . In a zebrafish xenograft tumor model, A2073 demonstrates significant anti-tumor cell proliferation activity while maintaining low toxicity. A2073 is suitable for research in acute erythroleukemia.
Smiles
O[C@]12[C@]([C@@H](C[C@H]1OC(CN3CCCCC3)=O)C4=CC=CC=C4)(OC=5C2=C(OC)C=C(OC)C5)C6=CC=C(OC)C=C6
Molecular Formula
C33H37NO7
Molecular Weight
559.65
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
E3452-45Z1-ML490 100 µL
ERK1, NT (Extracellular Signal-regulated Kinase 1, ERK-1, ERT2, Insulin-stimulated MAP2 Kinase, MAP Kinase Isoform p44, Microtubule-associated Protein 2 Kinase, Mitogen-activated Protein Kinase 3, MAP Kinase 3, MAPK 3, MAPK3, Mitogen-activated Protein Kinase 1, MAP Kinase 1, MAPK 1, P44ERK1, p44-ERK1, P44MAPK, p44-MAPK, PRKM3) (MaxLight 490) discontinued
Sign In for Pricing
View Details orb3117020 100 µg
Cyclin B1/CCNB1 Rabbit Polyclonal Antibody (Fluoro488)
Sign In for Pricing
View Details 
bs-15533R-Cy5 100 µL
Bcl-2 alpha Polyclonal Antibody, Cy5 Conjugated
Sign In for Pricing
View Details 